Sandbox:Soroush: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 72: Line 72:


{|Class="wikitable"
{|Class="wikitable"
|border="1"
|+ 3rd Table
|+ 3rd Table
! Avvvval
! Avvvval
Line 79: Line 80:
|}
|}
==jadval==
==jadval==
{|Class="wikitable"
{|Class="wikitable"
|+4th Table
|+4th Table

Revision as of 17:12, 10 January 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Overview

Pathophysiology

Pathogenesis

  • The pathogenesis of disease xyz is as follows:
    • gsadjsdj
    • ds,and,n
  • ansdkfsk

ldsfjsjf

  • dhs
adksd
,ks,KDSA

antioxidants

  • antioxidants dilemma [1]
Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 4584


My First Table
0 1 2 3
1 2 3 4
0


Second Table
A1 AA2 !AAA3
1 2 3
border="1"
3rd Table
Avvvval 1 2 3 ! dovom 1 2 3

jadval

4th Table
Avvvval
1 2 3
! dovom
1 2 3


Soroush Seifirad, M.D.[3]

Soroush Seifirad CV

Address

  • 930 commmonwealth
    • Baim institute
      • clinical research
  1. Education
    1. NODET
    2. TUMS
      1. TBZMD

Published articles

  1. Pirfenidone
  2. Pirfenidone
  3. pirfenidone

Clinical trials

  • RCTs

"hello"

  1. how are you? aaa bbb
    1. I am fine thank you

"I think I have to make a table now and insert some pictures"

conference

  • Spain
  • Netherlands


References

  1. Seifirad S, Ghaffari A, Amoli MM (2014). "The antioxidants dilemma: are they potentially immunosuppressants and carcinogens?". Front Physiol. 5: 245. doi:10.3389/fphys.2014.00245. PMC 4094884. PMID 25071590 PMID: 25071590 Check |pmid= value (help).